awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41593651-16D09060-E39D-4476-B4B1-8A610C630BF2
Q41593651-16D09060-E39D-4476-B4B1-8A610C630BF2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41593651-16D09060-E39D-4476-B4B1-8A610C630BF2
Long-term outcomes of primary systemic light chain (AL) amyloidosis in patients treated upfront with bortezomib or lenalidomide and the importance of risk adapted strategies.
P2860
Q41593651-16D09060-E39D-4476-B4B1-8A610C630BF2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41593651-16D09060-E39D-4476-B4B1-8A610C630BF2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6fd9a33b7199ed8d74e65e3a9e5f0b9aad3769eb
P2860
The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis.